Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
107 participants
INTERVENTIONAL
2017-10-12
2018-02-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Comparison of DDT2 Contact Lens and a Daily Disposable Contact Lens - Study 2
NCT03888482
Daily Disposable Dispensing Clinical Trial of Test Lens Against Stenfilcon A Lens
NCT03024970
Two Daily Disposable Contact Lenses in Symptomatic Patients
NCT03628599
Clinical Evaluation of Daily Disposable Contact Lenses
NCT02097030
Clinical Comparison of Two Daily Disposable Soft Contact Lenses
NCT03518008
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DD T2
Verofilcon A contact lenses worn in both eyes for 3 months in a daily wear, daily disposable modality. A new pair of study lenses will be inserted each day and discarded at the end of the day.
verofilcon A contact lenses
Daily disposable soft contact lenses
DT 1
Delefilcon A contact lenses worn in both eyes for 3 months in a daily wear, daily disposable modality. A new pair of study lenses will be inserted each day and discarded at the end of the day.
delefilcon A contact lenses
Daily disposable soft contact lenses
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
verofilcon A contact lenses
Daily disposable soft contact lenses
delefilcon A contact lenses
Daily disposable soft contact lenses
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Best corrected VA 20/25 or better in each eye.
Exclusion Criteria
* Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alcon, a Novartis Division
Role: STUDY_DIRECTOR
Alcon, a Novartis Division
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alcon Investigative Site
San Diego, California, United States
Alcon Investigative Site
Longwood, Florida, United States
Alcon Investigative Site
Maitland, Florida, United States
Alcon Investigative Site
Bloomington, Illinois, United States
Alcon Investigative Site
Brentwood, Tennessee, United States
Alcon Investigative Site
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLE383-C005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.